期刊
ENDOCRINE JOURNAL
卷 59, 期 10, 页码 919-929出版社
JAPAN ENDOCRINE SOC
DOI: 10.1507/endocrj.EJ12-0111
关键词
Cardionlyopathy; Heart failure; Thyrotoxicosis; Renin-angiotensin system; Echocardiography
资金
- Pusan National University Hospital
This study evaluated the effects of irbesartan and propranolol on thyroid hormone (TH)-induced cardiac functional and structural remodeling. A rat model of thyrotoxicosis was established by daily intraperitoneal injections of L-thyroxine (T-4, 100 mu g/kg) for 4 weeks. Forty Sprague-Dawley rats were randomly divided into four groups (n = 10 each): control group, T-4 group (T-4 alone), T-4 plus irbesartan group (T-4-lrb, 30 mg/kg), and T-4 plus propranolol group (T-4-Pro, 0.5mg/mL of drinking water). Cardiac chamber size and functional parameters were measured by echocardiography and cardiomyocyte diameter. Heart rate (FIR) and cardiac fibrosis were determined. T-4 alone showed significantly increased HR and cardiomyocyte width (25.0 +/- 1.77 vs. 18.8 +/- 0.84 mu m, P<0.001) with fibrosis, reduced left ventricle (LV) longitudinal strain (S-long; -16.0 +/- 6.27 vs. -22.7 +/- 5.19 %, P < 0.001) compared with control. When compared with T-4 alone, T-4-lrb showed significantly improved LV S-long (-21.4 +/- 1.84 vs. -16.0 +/- 6.27%, P=0.017) and reduced cardiomyocyte width (21.0 +/- 1.0 vs. 25.0 +/- 1.77 mu m, P=0.002) with comparable HR (458.4 +/- 24.3 vs. 486.6 +/- 30.1 bpm, P = 0.086). However, T-4-Pro showed significantly reduced HR with improved LV S-long without alteration of cardiomyocyte width and fibrosis compared with T-4 alone. In conclusion, renin-angiotensin system (RAS) blocking by irbesartan could significantly attenuate TH-induced cardiac structural and functional remodeling. However, HR reduction by propranolol could not alternate structural remodeling, which may implicate the RAS as having an important role in thyrotoxic cardiomyopathy beyond tachycardia.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据